Overall, as GLP-1RAs become increasingly prescribed, further pharmacovigilance studies are warranted
Since the development of the first GLP-1 medication, Byetta, by Amylin Pharmaceuticals in 2005 and its commercialization by AstraZeneca, these drugs have been widely used for managing type 2 diabetes
As with any supplement, it isn't intended for use during pregnancy or breastfeeding without medical advice, and results build gradually with consistent daily use rather than overnight, so routine matters as much as the formula itself
IV therapy makes sense in specific circumstances: GI absorption issues (IBS, IBD, post-bariatric, celiac), acute high-demand windows (illness recovery, event preparation, peak training), need for rapid serum restoration (severe dehydration, post-event), patients on medications that impair absorption (PPIs, metformin), and patients who simply have not responded adequately to oral supplementation under physician guidance